A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

NCT04175847 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: RC88

Sponsor

RemeGen Co., Ltd.